Vaccines comprising oligonucleotides having immunostimulatory sequences (ISS) wherein the ISS are conjugated to antigens and stabilized by buffer conditions and further excipients

Details for Australian Patent Application No. 2006220835 (hide)

Owner Dynavax Technologies Corporation

Inventors Rodriguez, Roberto; Tuck, Stephen F.

Agent Davies Collison Cave

Pub. Number AU-B-2006220835

PCT Pub. Number WO2006/096497

Priority 60/658,947 04.03.05 US

Filing date 3 March 2006

Wipo publication date 14 September 2006

Acceptance publication date 19 January 2012

International Classifications

A61K 39/35 (2006.01) Medicinal preparations containing antigens or antibodies - Allergens

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/096497 Priority application(s): WO2006/096497

19 January 2012 Application Accepted

  Published as AU-B-2006220835

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006220848-Bag-in-a-box

2006220829-Anti-CTLA-4 antibody compositions